Showing results (31-40 of 7,608) with videos related to
Sort By:
Pageof 761
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing SunStatistical Communications in Infectious Diseases|December 15, 2010
Increasing the Efficiency of Prevention Trials by Incorporating Baseline CovariatesMin Zhang, Peter B GilbertJournal of the Royal Statistical Society. Series C, Applied Statistics|February 3, 2015
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trialsPeter B Gilbert, Yanqing SunScandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B GilbertLifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B GilbertClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B GilbertBiometrics|April 29, 2009
Assessing vaccine effects in repeated low-dose challenge experimentsMichael G Hudgens, Peter B GilbertBiostatistics (Oxford, England)|December 17, 2013
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyErin E Gabriel, Peter B GilbertContemporary Clinical Trials|August 23, 2005
Accuracy and precision of estimating intervention efficacy when the timing of observed events differ by treatment armAmalia S Meier, Peter B GilbertBiometrics|March 28, 2008
Evaluating candidate principal surrogate endpointsPeter B Gilbert, Michael G HudgensPageof 761